Viewing nowCombinationNotobajeng 5mg/10mg
Atorvastatin Calcium Hydrate 10.85mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Austin Pharmaceutical Co., Ltd.

MFDS item code 200809659 · Notified 2008.09.18 · Insurance code 654303810
Improvement of dyslipidemia; treatment of hypertension and angina; prevention of cardiovascular disease
This medication is designed for patients who require both amlodipine (esamlodipine) and atorvastatin. Amlodipine treats hypertension and myocardial ischemia caused by stable or variant angina, reducing the risk of hospital admissions for angina in patients with coronary artery disease and the risks associated with vascular surgery. Atorvastatin lowers the risk of myocardial infarction, stroke, and angina in adults with cardiovascular disease risk factors and in patients with type 2 diabetes. It is also effective for the treatment of dyslipidemia and plays an important role in the prevention and treatment of cardiovascular diseases and improving dyslipidemia. Therefore, this medication is used to manage and improve cardiovascular health.
This medicine is administered only to adults. The dose should be individualized for each patient based on the efficacy and tolerability of each component, amlodipine and atorvastatin. Adults: Administer amlodipine (S-amlodipine) 5 (2.5) mg orally once daily; depending on the patient's response, the dose may be increased to a maximum of 10 (5) mg daily. Adjust as appropriate according to symptoms. Patients receiving atorvastatin, whether before or during treatment, should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and combined (mixed) dyslipidemia (Fredrickson Type Ⅱa and Ⅱb) The recommended initial dose of this medicine is 10 mg once daily. However, patients requiring greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or greater is required). This medicine is administered at doses ranging from 10 mg ∼ 80 mg once daily and may be taken at any time of day, with or without food. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Analyze lipid levels within 2 ∼ 4 weeks after starting treatment and/or adjusting the dose, and adjust the dose accordingly. 2. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 mg ∼ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are unavailable. 3. Patients with renal failure Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. 4. Older adults The efficacy and safety in older adults aged 70 years and older are generally similar to those in the general adult patient population.
This medication should not be used for certain patients. For example, it should not be administered to patients with a history of allergy or hypersensitivity to this medication, similar types of medications, or its ingredients. It should also not be administered to patients with severely impaired liver function or active liver disease, patients whose serum aminotransferase levels are persistently elevated above three times the normal range, patients with cessation of bile secretion, and patients with muscle disorders. Pregnant women or women who may become pregnant, as well as nursing mothers, should not take this medication. Patients with severe aortic stenosis, shock conditions including cardiogenic shock, severe hypotension, patients within one month after a myocardial infarction, patients with unstable angina, and patients concurrently treated with certain hepatitis medications should also avoid this medication. Additionally, this medication should be used with caution in the following patients: Patients with severe kidney dysfunction or those requiring dialysis, elderly patients, patients with a history of alcoholism or liver disease, patients at high risk of muscle damage, patients with acute heart failure, patients in hypertensive crisis, patients with mild to moderate liver dysfunction, and patients with severe myasthenia gravis, among others. Possible adverse reactions during treatment include facial flushing due to vasodilation, fatigue, edema, palpitations, dizziness, headache, drowsiness, indigestion, myalgia, etc. Rarely, symptoms such as abnormal liver function, allergic reactions, skin rashes, hair loss, and increased sweating have also been reported. Regular liver function tests are required while taking this medication, and if symptoms of liver dysfunction appear, consultation with a doctor should be sought immediately. If symptoms like myalgia, muscle weakness, or weakness appear, they should be reported immediately, and in severe cases, the administration should be discontinued. Pregnant women or those who may become pregnant should not take this medication, and if pregnancy is confirmed during treatment, it should be discontinued immediately and a doctor should be notified. Nursing mothers should also not take this medication. This medication may interact with other drugs, so any other medications being taken should be reported to a doctor or pharmacist. Caution is especially needed when used in combination with medications that affect liver function or increase the risk of muscle damage. In case of overdose, severe hypotension, shock, heart problems, etc. may occur, requiring immediate emergency treatment. This medication should be kept out of reach of children, and it is advisable not to transfer it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent influence from air or moisture. The storage temperature should ideally be maintained between 1 degree and 30 degrees Celsius at room temperature. This helps to maintain the effectiveness of the medication over a long period.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAtorvastatin Calcium Hydrate 10.85mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Austin Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium Trihydrate 10.85mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Viatriss Korea Co., Ltd.
CombinationAtorvastatin Calcium Trihydrate 21.7mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Viatrise Korea Co., Ltd.
CombinationAtorvastatin Calcium Trihydrate 43.4mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Viatris Korea Co., Ltd.
CombinationAtorvastatin Calcium Hydrate 10.85mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Atorvastatin Calcium Trihydrate 10.36mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationAtorvastatin Calcium 20.72mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
CombinationAtorvastatin Calcium 10.36mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.